Literature DB >> 10956379

Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.

L C Mishra1, B B Singh, S Dagenais.   

Abstract

OBJECTIVE: The objective of this paper is to review the literature regarding Withania somnifera (ashwagandha, WS) a commonly used herb in Ayurvedic medicine. Specifically, the literature was reviewed for articles pertaining to chemical properties, therapeutic benefits, and toxicity.
DESIGN: This review is in a narrative format and consists of all publications relevant to ashwagandha that were identified by the authors through a systematic search of major computerized medical databases; no statistical pooling of results or evaluation of the quality of the studies was performed due to the widely different methods employed by each study.
RESULTS: Studies indicate ashwagandha possesses anti-inflammatory, antitumor, antistress, antioxidant, immunomodulatory, hemopoietic, and rejuvenating properties. It also appears to exert a positive influence on the endocrine, cardiopulmonary, and central nervous systems. The mechanisms of action for these properties are not fully understood. Toxicity studies reveal that ashwagandha appears to be a safe compound.
CONCLUSION: Preliminary studies have found various constituents of ashwagandha exhibit a variety of therapeutic effects with little or no associated toxicity. These results are very encouraging and indicate this herb should be studied more extensively to confirm these results and reveal other potential therapeutic effects. Clinical trials using ashwagandha for a variety of conditions should also be conducted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10956379

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  171 in total

1.  Targeting Notch Signaling in Colorectal Cancer.

Authors:  Suman Suman; Trinath P Das; Murali K Ankem; Chendil Damodaran
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

2.  Therapeutic effect of Withania somnifera on pristane-induced model of SLE.

Authors:  Ujla Minhas; Ranjana Minz; Prabir Das; Archana Bhatnagar
Journal:  Inflammopharmacology       Date:  2011-12-13       Impact factor: 4.473

3.  Functional characterization and differential expression studies of squalene synthase from Withania somnifera.

Authors:  Neha Gupta; Poonam Sharma; R J Santosh Kumar; Rishi K Vishwakarma; B M Khan
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

4.  Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.

Authors:  Joomin Lee; Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Carcinogenesis       Date:  2010-08-19       Impact factor: 4.944

Review 5.  Withania somnifera: From prevention to treatment of cancer.

Authors:  Dushani L Palliyaguru; Shivendra V Singh; Thomas W Kensler
Journal:  Mol Nutr Food Res       Date:  2016-01-29       Impact factor: 5.914

6.  Microbial secondary metabolites ameliorate growth, in planta contents and lignification in Withania somnifera (L.) Dunal.

Authors:  Akanksha Singh; Rupali Gupta; Madhumita Srivastava; M M Gupta; Rakesh Pandey
Journal:  Physiol Mol Biol Plants       Date:  2016-06-06

7.  Neuroprotective effects of Withania somnifera dunal.: A possible mechanism.

Authors:  Maheep Bhatnagar; Durgesh Sharma; Mahendra Salvi
Journal:  Neurochem Res       Date:  2009-05-15       Impact factor: 3.996

Review 8.  Phytochemicals as potential antidotes for targeting NF-κB in rheumatoid arthritis.

Authors:  R Kowshik Aravilli; S Laveen Vikram; V Kohila
Journal:  3 Biotech       Date:  2017-07-18       Impact factor: 2.406

Review 9.  Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.

Authors:  Avani R Vyas; Shivendra V Singh
Journal:  AAPS J       Date:  2013-09-18       Impact factor: 4.009

10.  A novel HSP90 modulator with selective activity against thyroid cancers in vitro.

Authors:  Abbas Samadi; Peter Loo; Rithwi Mukerji; Gemma O'Donnell; Xiaqin Tong; Barbara N Timmermann; Mark S Cohen
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.